跳至主要内容
临床试验/NCT04902339
NCT04902339已完成不适用

Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With Chronic Pain

University of Utah2 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2021年4月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
142
试验地点
2
主要终点
Blood oxygenation level dependent (BOLD) signaling

研究概览

简要总结

The primary aim of this pilot trial is to enhance the efficacy of the Mindfulness-Oriented Recovery Enhancement (MORE) intervention by adding neurofeedback (NF) of the Orbitofrontal Cortex (OFC) as an adjunct to the savoring component of MORE. We hypothesize that the use of NF to train OFC responses during savoring will amplify patients' ability to savor and thereby increase brain responsivity to natural rewards; such enhanced reward responding will in turn be associated with improvements in clinical outcomes (e.g., pain, analgesic use).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age,
  • ability to understand and speak the English language
  • current chronic pain-related diagnosis

排除标准

  • mindfulness training experience (e.g., participation in MBSR/MBRP)
  • neurofeedback experience
  • current cancer diagnosis
  • having a psychiatric or medical condition that precludes the ability to provide informed consent or participation in outpatient treatment (e.g., psychosis, mania, acute intoxication)
  • suicidal ideation with a plan in the past week, or a suicide attempt in the past 3 months
  • unwilling, unable, or unlikely to complete study procedures (e.g., planned major surgery, anticipated move, travel barrier)
  • communication or cognitive impairment that limits participation in group treatment or study procedures

结局指标

主要结局

Blood oxygenation level dependent (BOLD) signaling

时间窗: From baseline to immediately after the intervention.

Changes in blood oxygenation levels to reward cues will be assessed, and planned comparisons will be performed between subjects receiving MORE+NF vs the control conditions.

次要结局

  • Chronic pain symptoms(From baseline to 3-month follow-up.)
  • Pleasant sensation ratio(From baseline to immediately after intervention.)
  • Opioid misuse(From baseline to 3-month follow-up.)
  • Opioid dose(From baseline to 3-month follow-up.)
  • Savoring(From baseline to 3-month follow-up.)
  • Pleasure ratings(From baseline to immediately after intervention.)
  • Distress(From baseline to 3-month follow-up.)
  • Self-transcendence(From baseline to 3-month follow-up.)
  • Opioid craving(From baseline to 1-month follow-up.)
  • Positive affect(From baseline to 1-month follow-up.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验